Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep679 | Pituitary: basic and neuroendocrinology | ECE2015

Hyponatremia and mortality in patients hospitalised for heart failure (2005–2011)

Marco Javier , Crespo Irene , Ortola Ana , Gracia Teresa Ruiz , De Miguel Paz , Mendez Manuel , Nunez Karla , Lopez Judith , Duran Alejandra

Introduction: Hyponatremia is the most frequent electrolyte disorder in hospitalised patients. Our aim was to determine the incidence, mean hospital stay, readmission rate and mortality rate among patients with acute heart failure (HF) and hyponatremia.Methods: Retrospective analysis of data collected from the minimum data set (MDS) of Spanish National health System during 2005–2012 from discharged patients of Internal Medicine with HF and hyponatre...

ea0063p111 | Calcium and Bone 1 | ECE2019

The coincidence of primary hyperparathyroidism and primary hyperaldosteronism is not infrequent: a retrospective case analysis

Barrio Elvira , Ramos Elvira , Crespo Irene , Pallares Raquel , Pazos Mario , de Miguel Paz , Cuesta Martin , Jose Torrejon Maria , Calle Alfonso , Runkle Isabelle

Introduction: Primary hyperparathyroidism (PHP) has been postulated to be a cause of primary hyperaldosteronism (PHA). In fact, PTH receptors have been detected in aldosteronoma tissue. Hyperaldosteronism can also induce elevation of PTH levels, as increased circulating volume increases calciuria, with secondary elevation of PTH levels as serum calcium levels rise. We studied the prevalence of PHP in a group of patients diagnosed with PHA either following or simultaneously wit...

ea0063p443 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Type 1 gastric neuroendocrine tumor study in Hospital Clínico San Carlos (HCSC), Madrid

Ramos Elvira , Barrio Elvira , Vargas-Zuniga Ignacio , Pallares Raquel , Pazos Mario , Suarez Pablo , Aldama Paula , Sevilla Concepcion , De Miguel Paz , Diaz Jose Angel

Introduction: Type 1 Gastric neuroendocrine tumors account for 70 to 80 percent of all gastric neuroendocrine tumors (G-NETs) and they are found more commonly in older adults, particularly women. They are associated with autoimmune metaplastic atrophic gastritis (AMAG) with or without pernicious anemia. They are usually smaller than 1 cm and often multiple. Our goal is to describe different characteristics of type 1 G-NETs and to study possible prognostic factors related to th...

ea0037gp.26.06 | Thyroid – hypothyroidism | ECE2015

Analysis of hypothyroidism in patients admitted to internal medicine wards in Spain 2005–2012

Penso Rona , Duran Alejandra , Gracia Teresa Ruiz , Crespo Irene , Ortola Ana , De Miguel Paz , Mendez Manuel , Nunez Karla , Lopez Judith , Marco Javier

Introduction: Hypothyroidism (hT) is a very common disease that can affect inpatients prognosis. We analysed the clinical profile of patients with hT admitted to Internal Medicine using a large clinical-administrative database.Methods: A descriptive analysis based on the minimum-data-set database of the Spanish National health System of patients who were discharged from the services of Internal Medicine with the diagnoses of hT during 2005–2012 was ...

ea0037ep672 | Pituitary: basic and neuroendocrinology | ECE2015

The use of an oral salt load followed by furosemide in the treatment of euvolemic SIADH-induced hyponatremia

Ortola Ana , Crespo Irene , Ruiz-Gracia Teresa , Gomez-Hoyos Emilia , Cuesta Martin , Penso Rona , Amengual Angela , de Miguel Paz , Calle-Pascual Alfonso , Runkle Isabelle

Introduction: Furosemide can be used in the treatment of SIADH. However, to be effective, renal medulla osmolality (OsmRM) as reflected in urinary osmolality (UOSM) must be high. Sodium is the most important contributor to OsmRM, which increases following the administration of oral salt. We analyze the use of an oral salt load followed by furosemide for the acute/short-term treatment of euvolemic SIADH hyponatremia.Method...

ea0056oc10.4 | Cardiovascular aspects of endocrine diseases | ECE2018

Improvement in the control of hypertension in diabetic patients screened for hyperaldosteronism

Jimenez Ines , Crespo Irene , Cuesta Martin , Elvira Carlos , de Miguel Paz , Santiago Alejandro , Fernandez Luzdivina , de Parayuelo Maria Victoria Saez , Calle Alfonso , Runkle Isabelle

Introduction: Control of hypertension (HT) is essential to reduce cardiovascular events in diabetic patients (DPts). However, studies indicate that only 50% of DPts with treated hypertension present adequate blood pressure (BP) control. Yet Endocrine-Society-Guideline (ESG) screening for primary hyperaldosteronism (PHA) is rarely applied. Furthermore, in patients with essential hypertension (EH), longer-acting hypertension medication (HM) improves 24-hour BP when compared to r...

ea0041ep1118 | Thyroid cancer | ECE2016

Medullary thyroid cancer (MTC): descriptive analysis and prognostic factors in a multicenter study

Alcazar Victoria , Blanco Concepcion , Alvarez-Escola Cristina , Guijarro Guadalupe , Estrada Javier , De Miguel Paz , Palacios Nuria , Duran Alejandra , Carmen Montanes M. , Abad Ainhoa , Lecumberri Beatriz , Civantos Soralla , Aller Javier

Introduction: MTC accounts for 5% of thyroid cancers and can occur sporadically or as part of the multiple endocrine neoplasia type 2 syndrome (MEN 2). The objective of our study is to evaluate the prognostic factors and outcomes of patients with MTC in the community setting.Methods: Retrospective descriptive multicenter study of patients with histological diagnosis of MTC. Descriptive, bivariate analyses (Student t for cuantitative and ...

ea0070aep722 | Pituitary and Neuroendocrinology | ECE2020

Doses of tolvaptan needed in chronic therapy of SIADH-induced euvolemic hyponatremia vary according to the etiology of SIADH

Pérez Candel Xavier , Lopez Nevado Celia , Cuesta Martin , Angel Rodriguez Cabezas Miguel , Puebla Virginina , de Miguel Paz , Gomez Hoyos Emilia , Ruiz Teresa , Calle Pascual Alfonso , Runkle Isabel

Introduction: Clinical trials indicate that Tolvaptan is safe and effective in the treatment of patients with sustained mild/moderate SIADH-induced euvolemic hyponatremia. Tolvaptan doses are often modified during chronic use. We present the weekly doses of a series of patients on chronic therapy, followed up in outpatient clinic.Methods: Retrospective, cross-sectional. 114 patients receiving tolvaptan for chronic SIADH were followed up in a Hyponatremia...

ea0070aep908 | Thyroid | ECE2020

The use of different sodium/potassium perchlorate regimes could affect response time in the treatment of amiodarone-induced thyrotoxicosis

Pazos Mario , Cuesta Martín , Pallarés Raquel , Ramos Elvira , Barrio Elvira , Puebla Virginia , De Miguel Paz , Ángel Díaz Jose , Calle Alfonso , Runkle Isabelle

Introduction: In the treatment of amiodarone-induced type I or mixed thyrotoxicosis, sodium or potassium perchlorate is often associated to thionamides, when the latter are insufficient for a prompt control of thyroid hormone secretion. Perchlorate competes with iodine for entrance into the follicular cell, and also induces a discharge of iodine from these cells with each administration. We compare the effect of 3 different regimes of perchlorate with methimazole on control of...